| ID Source | ID |
|---|---|
| PubMed CID | 3034007 |
| CHEMBL ID | 2107483 |
| SCHEMBL ID | 2734592 |
| MeSH ID | M0124961 |
| Synonym |
|---|
| teopranitol |
| [(3s,3ar,6s,6as)-3-[3-(1,3-dimethyl-2,6-dioxopurin-7-yl)propylamino]-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate |
| 631r1kon85 , |
| teopranitol [inn] |
| teopranitolum [inn-latin] |
| 1,4:3,6-dianhydro-2-deoxy-2-((3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurin-7-yl)propyl)amino)-l-iditol 5-nitrate |
| 81792-35-0 |
| teopranitolum |
| unii-631r1kon85 |
| CHEMBL2107483 |
| SCHEMBL2734592 |
| Q27263542 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, in the presence of the EDRF stimulator acetylcholine, the dose-response curve to SNP was shifted to right in the aorta as well." | ( Endothelium-derived relaxant factor inhibits effects of nitrocompounds in isolated arteries. Busse, R; Pohl, U, 1987) | 0.27 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||